NCT00511173View on ClinicalTrials.gov

Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Atrial FibrillationPulmonary EmbolismDeep Vein Thrombosis
Interventions
GENETIC

Warfarin Dose based on pharmacogenetics

Warfarin dose adjustment will be based on the standard clinician dosing compared to the use of the pharmacogenetic base algorithm

All Listed Sponsors
lead

Creighton University

OTHER

NCT00511173 - Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm | Biotech Hunter | Biotech Hunter